spacer
home > ict > winter 2020 > comparator sourcing in china: three key trends for a new decade
PAY PER VIEW SERVICE

 

Dear guest!

article: Comparator Sourcing in China: Three Key Trends for a New Decade
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

Cumulus Neuroscience Commences Clinical Studies of Digital Biomarker Platform in Degenerative Neurological Diseases

Belfast, UK – 25 May 2022. Cumulus Neuroscience, a global digital health company, announces the start of two validation trials – CNS-101 and CNS-102 – supported by a group of leading global pharma companies and Innovate UK. The studies will investigate the potential benefits of Cumulus’ integrated physiological and digital biomarker platform in quantifying cognitive decline over time in patients with dementia, across AD, ALS and FTD.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement